Genenta Science S.p.A. is a biotechnology company focused on developing gene and cell therapies for the treatment of cancer. It is dedicated to harnessing the power of its proprietary technology platform to create targeted immunotherapies that have the potential to revolutionize cancer treatment. With a strong pipeline of innovative therapies in development, Genenta Science is poised to make a significant impact in the field of oncology.
